Applied Spectral Imaging

Company Overview

Snapshot

Founded in February 1993, Applied Spectral Imaging operates with 51–200 employees. The company has raised $11 million across 3 funding rounds from 3 investors. A significant milestone for the company was its acquisition by ZYTOMICS in August 2025.

Business overview

Applied Spectral Imaging (ASI) develops biomedical microscopy imaging solutions, providing end-to-end platforms for Pathology, Cytogenetics, and Research laboratories. Its core technology, GenASIs, combines image acquisition with computer-assisted analysis, enabling advanced diagnostics through powerful algorithms and customer-focused software. The company offers a wide portfolio of dedicated solutions for Brightfield, Fluorescence, and Spectral imaging and analysis, including products like HiPath Pro, PathFusion, HiBand, HiFISH, CytoPower, and Rainbow, serving clinical laboratories, life science companies, and research institutions.

Strategic signal

In August 2025, Applied Spectral Imaging was acquired by ZYTOMICS. This acquisition signals a successful exit for ASI, validating its technology and market position in biomedical imaging. For investors and innovation teams, this indicates the strategic value of ASI's automated imaging platforms and its potential for integration into larger diagnostic ecosystems, suggesting a strong return on investment and continued impact within the health tech and life sciences sector.

Company Intelligence Q&A

What was a significant recent corporate development for Applied Spectral Imaging?

In August 2025, Applied Spectral Imaging was acquired by ZYTOMICS, marking a key exit event for the company.

When did Applied Spectral Imaging enter a strategic commercial partnership with KromaTiD?

In April 2021, Applied Spectral Imaging entered a strategic commercial partnership with KromaTiD, Inc., granting ASI worldwide rights to market KromaTiD's proprietary Pinpoint FISH™ (PPF) probes and assay services.

What product update did Applied Spectral Imaging launch in January 2019?

In January 2019, Applied Spectral Imaging launched a product update that included a novel imaging methodology and advanced hardware components to increase scanning speed for FISH imaging, enhancing diagnostic confidence and workflow efficiencies for pathology and cytogenetic laboratories.

What was the outcome of the collaboration between ARUP Laboratories and Applied Spectral Imaging?

In November 2017, ARUP Laboratories and Applied Spectral Imaging completed a multi-year collaboration, resulting in the launch of ASI's PathFusion, a solution combining Whole Slide Imaging, Tissue FISH analysis, and digital tissue-matching of FISH with Brightfield samples.

What new products did Applied Spectral Imaging launch in October 2017?

In October 2017, Applied Spectral Imaging launched PathFusion and HiPath Pro, two new products for the digital pathology market designed to integrate Brightfield pathology and FISH imaging & analysis for improved diagnostic accuracy and laboratory productivity.